Biotech Values

[ghmm]

Thanks for the link.

Actually had come across Pipex a little while ago. Before I could do some DD on them stock went from the 1's to now in the 6's which puts the market cap in the 300-400 million range. I wish I had done some DD faster on it as I may have bought but now I see it as pretty pricey considering they'll need more cash to go through Phase 3 and the other use of tetrathiomolybdate (WIlson's Disease) seems to not offer much of a market opportunity (considering price of other drugs in class). If it drops back down and their future funding/partnering clears up I'll look at them more closely.

I've pretty much come to the conclusion that Pulmonary Fibrosis in general is really more akin to treatments for Cancer rather then other diseases (even PAH). I think combination therapy will be used and some will respond to some treatments/combinations better then others. I also think slight improvements (slowing progression of the disease) will be considered major advances at this stage (which is the big difference with PAH). And of course I think pricing of therapies will be along the lines of some of the newer higher priced oncology drugs (and PAH drugs).